Vistagen Therapeutics Inc (VTGN) Q2 2025 Earnings Call Highlights: Navigating Challenges with a ... [Yahoo! Finance]
VistaGen Therapeutics, Inc. (VTGN)
Last vistagen therapeutics, inc. earnings: 2/13 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vistagen.com
Company Research
Source: Yahoo! Finance
General Administrative Expenses: $4.2 million for the quarter ended September 30, 2024, compared to $3.2 million for the same period last year. Net Loss: $13 million for the quarter ended September 30, 2024, compared to $6.6 million for the same period last year. Cash, Cash Equivalents, and Marketable Securities: $97.6 million as of September 30, 2024. Warning! GuruFocus has detected 2 Warning Signs with VTGN. Release Date: November 07, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Vistagen Therapeutics Inc ( NASDAQ:VTGN ) is advancing a unique neuroscience pipeline with multiple clinical-stage product candidates in Phase 2 and Phase 3 development. The company has observed statistically significant efficacy and favorable safety data in its lead intranasal pherine development programs. Vistagen Therapeutics Inc ( NASDAQ:VTGN ) is targeting high-prevalence pharmaceutical markets with differentiated intranasal th
Show less
Read more
Impact Snapshot
Event Time:
VTGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTGN alerts
High impacting VistaGen Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VTGN
News
- Vistagen Reports Fiscal Year 2025 Second Quarter Financial Results and Corporate UpdateBusiness Wire
- Vistagen Therapeutics Inc (VTGN) Q2 2025 Earnings Report Preview: What to Expect [Yahoo! Finance]Yahoo! Finance
- Vistagen to Present at the 2024 Neuroscience Education Institute CongressBusiness Wire
- Vistagen to Report Fiscal Year 2025 Second Quarter Results and Host Corporate Update Conference Call on November 7, 2024Business Wire
- VistaGen Therapeutics (VTGN) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]Yahoo! Finance
VTGN
Earnings
- 11/7/24 - Miss
VTGN
Sec Filings
- 11/7/24 - Form 8-K
- 11/7/24 - Form 10-Q
- 9/23/24 - Form 8-K
- VTGN's page on the SEC website